Shanghai Fosun Pharmaceutical Reported to Halt Sale of Stake in Gland Pharma
Indian media sources, including ET Now, have reported that Shanghai Fosun Pharmaceutical Group Co., Ltd...
Deals
LaNova Medicines and LegoChem Biosciences Partner to Develop Innovative ADC Product
Shanghai-based cancer therapy developer LaNova Medicines Ltd has entered into a research partnership agreement with...
Sunshine Guojian Pharmaceutical and Shenyang 3SBio Secure Exclusive Licensing Agreement for Antitumor Programs
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a subsidiary of 3SBio Inc. (HKG: 1530), has announced...
Ping An Healthcare and Technology Partners with Chugai Pharmaceutical to Establish Angina Pectoris Center
Ping An Healthcare and Technology Co., Ltd (HKG: 1833), also recognized as PingAn Good Doctor,...
Tot Biopharmaceutical and Shanghai Escugen Partner on ADC Development and Commercialization
China-based Tot Biopharmaceutical International Co., Ltd (HKG: 1875) has announced a strategic partnership with Shanghai...
Meilitech Secures Series A+ Funding Led by Autobio Diagnostics for Cancer Detection Tech
Shenzhen-based nanopore early cancer detection product developer, Meilitech Co., has reportedly raised tens of millions...
Sable Therapeutics and Liuqiang Medical Ink Licensing Deal for Aesthetic Fat Reduction Patch
US-based Sable Therapeutics has announced plans to sign a licensing agreement with China-based Liuqiang Medical...
Beijing-Based Holox Secures Tens of Millions in Series A+ Financing for Healthcare Software
Holox, a Beijing-based developer of healthcare management software, has reportedly secured tens of millions of...
Shanghai Kingstar Winning Secures $43.39 Million in Series C Financing for Digital Healthcare Solutions
Shanghai Kingstar Winning Software Science and Technology Co., Ltd, a leading provider of digitalization risk...
Luzhu Biotech Prepares for HKD 433 Million IPO with Focus on Vaccines and Biologics
Beijing Luzhu Biotechnology Co., Ltd, a leading manufacturer of human vaccines and therapeutic biologics, is...
Tot Biopharmaceutical Partners with Suzhou Smart Nuclide on Radioactive Drug Development
China-based Tot Biopharmaceutical International Co., Ltd (HKG: 1875) has announced a strategic partnership with Suzhou...
Grand Pharmaceutical Group to Acquire Majority Stake in BlackSwan Vascular Inc. for $37.5 Million
Grand Pharmaceutical Group Limited (HKG: 0512), a China-based pharmaceutical company, has announced plans to acquire...
Suzhou Basecare Medical and Qitan Tech Partner to Advance Nanopore Sequencing in PGT
Suzhou Basecare Medical Co., Ltd (HKG: 2170), a China-based in vitro fertilization (IVF) specialist, has...
CanSino Biotechnology Leads RMB 500 Million Private Equity Fund for Vaccine Investments
China-based vaccines specialist CanSino Biotechnology Inc., (HKG: 6185) has announced plans to invest RMB 140...
PharmaEssentia Corporation Completes Secondary Offering of GDR Shares on Luxembourg Exchange
Taiwan-based PharmaEssentia Corporation (TPE: 6446) has announced the successful closing of a secondary offering of...
Siemens Healthineers and China Chest Pain Center Launch Smart Training Program
German healthcare giant Siemens Healthineers (ETR: SHL) has partnered with the China Chest Pain Center...
Biosion Secures Series B+ Financing to Advance Antibody-Based Therapies Pipeline
Biosion, a global, clinical-stage biotech company dedicated to developing antibody-based therapies for immune and oncologic...
HealZen Therapeutics and NeuShen Seal Deal for Global Rights to CNS Drug Programs
China-based HealZen Therapeutics has entered into a licensing agreement with compatriot firm NeuShen, focusing on...
Hasten Biopharmaceutical Secures $315 Million Investment for Pipeline Expansion
China-based Hasten Biopharmaceutical Co., Ltd has reportedly received USD 315 million in a fundraising round...
Staidson Pharmaceutical Plans RMB 580 Million Private Placement for Drug R&D
China-based Staidson (Beijing) Pharmaceutical Co., Ltd (SHE: 300204) has announced plans to raise RMB 580...